How antibodies block HIV infection : paths to an AIDS vaccinePUTNEY, S.Trends in biochemical sciences (Amsterdam. Reference ed.). 1992, Vol 17, Num 5, pp 191-196, issn 0376-5067Article

ADVANCES IN SEMICRYSTALLINE SILICON SOLAR CELLSPUTNEY S; STORTI G; WRIGLEY C et al.1982; PHOTOVOLTAIC SPECIALISTS CONFERENCE. 16/1982-09-27/SAN DIEGO CA; USA; NEW YORK: IEEE; DA. 1982; PP. 1463-1564; BIBL. 2 REF.Conference Paper

Antigenic variation in HIVPUTNEY, S. D; MCKEATING, J. A.AIDS (London). 1990, Vol 4, pp S129-S136, issn 0269-9370, SUPConference Paper

Isolation of a functional human gene for brain creatine kinaseDAOUK, G. H; KADDURAH-DAOUK, R; PUTNEY, S et al.The Journal of biological chemistry (Print). 1988, Vol 263, Num 5, pp 2442-2446, issn 0021-9258Article

Improving protein therapeutics with sustained-release formulationsPUTNEY, S. D; BURKE, P. A.Nature biotechnology. 1998, Vol 16, Num 2, pp 153-157, issn 1087-0156Article

Recombinant human growth hormone poly(lactic-co-glycolic acid) microsphere formulation developmentCLELAND, J. L; JOHNSON, O. L; PUTNEY, S et al.Advanced drug delivery reviews. 1997, Vol 28, Num 1, pp 71-84, issn 0169-409XArticle

Production and characterization of fusion proteins containing transferrin and nerve growth factorPARK, E; STARZYK, R. M; MCGRATH, J. P et al.Journal of drug targeting. 1998, Vol 6, Num 1, pp 53-64, issn 1061-186XArticle

B and T cell reactivities after immunization of macaques with HIV subcomponentsWAHREN, B; CHIODI, F; LJUNGGREN, K et al.AIDS research and human retroviruses. 1988, Vol 4, Num 3, pp 199-210, issn 0889-2229Article

The rabbit muscle phosphofructokinase gene: implications for protein structure, function, and tissue specificityCHAN-PING LEE; MING-CHING KAO; FRENCH, B. A et al.The Journal of biological chemistry (Print). 1987, Vol 262, Num 9, pp 4195-4199, issn 0021-9258Article

A large-scale process to produce microencapsulated proteinsHERBERT, P; MURPHY, K; JOHNSON, O et al.Pharmaceutical research. 1998, Vol 15, Num 2, pp 357-361, issn 0724-8741Article

Synthetic peptide derived from the Bordetella pertussis bacterium reduces infarct volume after transient middle cerebral artery occlusion in the ratZHANG, R. L; CHOPP, M; TANG, W. X et al.Neurology. 1996, Vol 46, Num 5, pp 1437-1441, issn 0028-3878Article

Structural requirements for class I MHC molecule-mediated antigen presentation and cytotoxic T cell recognition of an immunodominant determinant of the human immunodeficiency virus envelope proteinTAKAHASHI, H; HOUGHTEN, R; PUTNEY, S. D et al.The Journal of experimental medicine. 1989, Vol 170, Num 6, pp 2023-2035, issn 0022-1007Article

Cerebral cell adhesion molecule : A novel leukocyte adhesion determinant on blood-brain barrier capillary endotheliumSTARZYK, R. M; ROSENOW, C; FRYE, J et al.The Journal of infectious diseases. 2000, Vol 181, Num 1, pp 181-187, issn 0022-1899Article

Construction of peptides encompassing multideterminant clusters of human immunodeficiency virus envelope to induce in vitro T cell responses in mice and humans of multiple MHC typesBERZOFSKY, J. A; PENDLETON, C. D; CLERICI, M et al.The Journal of clinical investigation. 1991, Vol 88, Num 3, pp 876-884, issn 0021-9738Article

Human monoclonal antibody that recognizes the V3 region of human immunodeficiency virus gp120 and neutralizes the human T-lymphotropic virus type III_MN strainSCOTT, C. F; SILVER, S; PROFY, A. T et al.Proceedings of the National Academy of Sciences of the United States of America. 1990, Vol 87, Num 21, pp 8597-8601, issn 0027-8424, 5 p.Article

Peptide from a prokaryotic adhesin blocks leukocyte migration in vitro and in vivoROZDZINSKI, E; SPELLERBERG, B; VAN DER FLIER, M et al.The Journal of infectious diseases. 1995, Vol 172, Num 3, pp 785-793, issn 0022-1899Article

Antibody-mediated in vitro neutralization of human immunodeficiency virus type 1- abolishes infectivity for chimpanzeesEMINI, E. A; NARA, P. L; GERETY, R. J et al.Journal of virology. 1990, Vol 64, Num 8, pp 3674-3678, issn 0022-538X, 5 p.Article

Mutations in the principal neutralization determinant of human immunodeficiency virus type 1 affect syncytium formation, virus infectivity, growth kinetics, and neutralizationGRIMAILA, R. J; FULLER, B. A; RENNERT, P. D et al.Journal of virology. 1992, Vol 66, Num 4, pp 1875-1883, issn 0022-538XArticle

Specific cellular immune response and neutralizing antibodies in goats immunized with native or recombinant envelope proteins derived from human T-lymphotropic virus type III_B and in human immunodeficiency virus-infected menKROHN, K; ROBEY, W. G; PUTNEY, S et al.Proceedings of the National Academy of Sciences of the United States of America. 1987, Vol 84, Num 14, pp 4994-4998, issn 0027-8424Article

An HTLV-III peptide produced by recombinant DNA is immunoreactive with sera from patients with AIDSCHANG, N. T; HUANG, J; GHRAYEB, J et al.Nature (London). 1985, Vol 315, Num 6015, pp 151-154, issn 0028-0836Article

A formalin inactived whole siv vaccine and a glycoprotein-enriched subunit vaccine confers protection against experimental challenge with pathogenic live siv in rhesis monkeusMURPHEY-CORB, M; MARTIN, L. N; ALLISON, A. C et al.Developments in biological standardization. 1990, Num 72, pp 273-285, issn 0301-5149, 13 p.Conference Paper

Helper T-cell antigenic site identification in the acquired immunodeficiency syndrome virus gp120 envelope protein and induction of immunity in mice to the native protein using a 16-residue synthetic peptideCEASE, K. B; MARGALIT, H; BERZOFSKY, J. A et al.Proceedings of the National Academy of Sciences of the United States of America. 1987, Vol 84, Num 12, pp 4249-4253, issn 0027-8424Article

Development and monitoring of purification process for nerve growth factor fusion antibodyHUNT, A. J; LYNCH, P. D; PUTNEY, S et al.Journal of chromatography. A. 1995, Vol 708, Num 1, pp 61-70Conference Paper

Priming with T helper cell epitope peptides enhances the antibody response to the envelope glycoprotein of HIV-1 in primatesHOSMALIN, A; NARA, P. L; BERZOFSKY, J. A et al.The Journal of immunology (1950). 1991, Vol 146, Num 5, pp 1667-1673, issn 0022-1767, 7 p.Article

Broadly neutralizing antibodies elicited by the hypervariable neutralizing determinant of HIV-1JAVAHERIAN, K; LANGLOIS, A. J; LAROSA, G. J et al.Science (Washington, D.C.). 1990, Vol 250, Num 4987, pp 1590-1593, issn 0036-8075Article